Drugs Made In America Acquisition (DMIIU) Return on Assets [ROA] (2026)
Drugs Made In America Acquisition's Return on Assets [ROA] came in at 1.76% for FY2025.
Powered by 
Analysis
Drugs Made In America Acquisition (DMIIU) Return on Assets [ROA] (2026) Analysis & Trends
Peer Set
Peer Comparison
API Access
Drugs Made In America Acquisition Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DMIIU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "DMIIU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=DMIIU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();